Filing Details

Accession Number:
0001209191-16-138836
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-08-26 17:52:09
Reporting Period:
2016-08-22
Filing Date:
2016-08-26
Accepted Time:
2016-08-26 17:52:09
Original Submission Date:
2016-08-24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879407 Arrowhead Pharmaceuticals Inc. ARWR Pharmaceutical Preparations (2834) 460408024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486672 Allen Kenneth Myszkowski 225 S. Lake Avenue
Suite 1050
Pasadena CA 91101
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-22 13,100 $2.01 128,789 No 4 M Direct
Common Stock Disposition 2016-08-22 13,100 $8.00 115,689 No 4 S Direct
Common Stock Acquisiton 2016-08-23 6,900 $2.01 122,589 No 4 M Direct
Common Stock Disposition 2016-08-23 6,900 $8.00 115,689 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-08-22 13,100 $0.00 13,100 $2.01
Common Stock Stock Option (right to buy) Disposition 2016-08-23 6,900 $0.00 6,900 $2.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
348,900 2013-06-01 2023-05-06 No 4 M Direct
342,000 2013-06-01 2023-05-06 No 4 M Direct
Footnotes
  1. Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
  3. Represents first vesting date. Option vests over four years from date of grant.